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α1-microglobulin (A1M) is a 26 kDa plasma and tissue protein with reductase activity
and radical- and heme-binding anti-oxidative functions. In addition, exposure of A1M to
hemoglobin has been shown to induce proteolytic elimination of a C-terminal tetrapeptide
yielding a heme-degrading form, truncated A1M (t-A1M). Myeloperoxidase (MPO), a
heme-containing enzyme that catalyzes the production of free radicals and hypochlorite,
is released by neutrophils during the inflammatory response to bacterial infections.
MPO-induced low density lipoprotein (LDL)-oxidation in blood has been suggested as a
causative factor in atherosclerosis. In this study we have hypothesized that A1M interacts
with MPO in a similar mode as with hemoglobin, and is a regulator of its activity. The
results show that A1M is proteolytically cleaved, with formation of t-A1M, after exposure
to MPO, and that t-A1M contains iron and heme-degradation products. The reaction
is dependent of pH, time and concentration of substrates and a pH-value around 7
is shown to be optimal for cleavage. Furthermore, A1M inhibits MPO- and hydrogen
peroxide-induced oxidation of LDL. The results suggest that A1M may have a role as an
inhibitor of the damaging effects of the neutrophil respiratory burst on bystander tissue
components.
Keywords: α1-microglobulin, myeloperoxidase, low density lipoprotein, C-terminal proteolysis, heme binding,
neutrophils
INTRODUCTION
The heme-containing enzyme myeloperoxidase (MPO) is a
cationic dimer with a molecular mass of 146 kDa. The enzyme
is stored in azurophil granules of non-stimulated neutrophils
and participates in killing of microorganisms during phagocytosis
(Nauseef and Malech, 1986; Malle et al., 2007). The enzyme cat-
alyzes the conversion of hydrogen peroxide and chloride to the
bactericidal compound hypochlorous acid/hypochlorite (Malle
et al., 2007). MPO is a major component of the azurophil gran-
ules and is released into the extracellular compartment when
de-granulation of the neutrophil is induced by various stimuli
(Farschou and Borregaard, 2003). Hypochlorite and free radi-
cals are important weapons against bacteria, but they also have
the negative effect of oxidizing by-stander tissue components
(Winrow et al., 1993; Klebanoff, 2005). MPO and the reactive
intermediates it generates have been identified in atherosclerotic
lesions and MPO may thus contribute to the oxidation of low
density lipoproteins (LDL) that ultimately leads to atherosclerosis
(Daugherty et al., 1994).
Abbreviations: A1M, α1-microglobulin; t-A1M, truncated A1M;MPO,myeloper-
oxidase; LDL, low density lipoprotein; ROS, reactive oxygen species; protein
HC, human complex-forming protein heterogeneous-in-charge; LIPR, leucine-
isoleucine-proline-arginine; FPLC, fast flow liquid chromatography; PIXE, proton-
induced X-ray emission; TBA, thiobarbituric acid; MS, mass spectrometry.
α1-microglobulin (A1M), also called protein HC, a plasma and
tissue protein with antioxidative properties, was first discovered
in human urine about 40 years ago (Ekström et al., 1975). It has
a mass of 26 kDa, consists of 183 amino acid residues, and has
been identified in a wide range of other species (Åkerström and
Gram, 2014). A1M is a member of the lipocalin family of struc-
turally related proteins in bacteria, plants and animals (Åkerström
et al., 2006). The recently published crystal structure shows that
the protein consists of an eight-stranded, anti-parallel β-barrel
with a highly conserved cysteine residue in position 34 located in
a loop near the open top of the beta-barrel (Meining and Skerra,
2012). The lipocalin pocket inside the β-barrel serves as a ligand-
binding entity in many of the lipocalins (Flower, 1996). A1M
is synthesized and secreted from liver and most other epithelial
cells, and present in blood and all tissues at remarkably con-
stant concentrations, 1–2μM (DeMars et al., 1989). The protein
is found in blood and tissues both in free form and bound to
immunoglobulin A, albumin or prothrombin (Berggård et al.,
1997).
A1M has been suggested to have a physiological function as
a cell and tissue protective antioxidant that operates by clearing
extravascular fluids of free radicals and heme groups (reviewed
in Olsson et al., 2012; Åkerström and Gram, 2014). To achieve
this, A1M employs enzymatic reductase, radical-scavenging, and
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heme-binding properties (Allhorn et al., 2002, 2005; Larsson
et al., 2004; Åkerström et al., 2007). Several recent publications
demonstrate that A1M indeed has powerful protective effects
in vivo and in vitro against oxidative damage from free radicals,
extracellular hemoglobin and free heme groups released during
hemolysis (Olsson et al., 2008, 2011; May et al., 2011; Rutardottir
et al., 2013; Rosenlöf et al., 2014; Sverrisson et al., 2014).
Hemolysis and release of free hemoglobin occurring in dif-
ferent pathological states results in generation of reactive oxygen
species (ROS) by autooxidation of the oxy-hemoglobin molecule,
and in increased levels of free heme (Olsson et al., 2012). Free
heme and ROS contributes to oxidation, covalent cross-linking
and aggregation of proteins, induce oxidative DNA-lesions, and
catalyze the formation of cytotoxic lipid peroxidation (Kumar
and Bandyopadhyay, 2005). Heme has been shown to be a
pro-inflammatory molecule in pathological conditions like renal
failure, atherosclerosis and heart transplant failure (Kumar and
Bandyopadhyay, 2005). The heme-binding by A1M thus con-
tributes to its antioxidative protective effects. The ability of A1M
to bind heme has also been observed in four other mammals and
fish (Larsson et al., 2004). When exposed to purified hemoglobin
or lysed erythrocytes, a truncated A1M (t-A1M) is formed, lack-
ing the C-terminal tetrapeptide LIPR (Allhorn et al., 2002). The
presence of t-A1M in human urine indicates that this reaction
occurs in vivo. T-A1M binds heme similar to full-length A1M
but also shows a time-dependent spectral rearrangement indi-
cating degradation of heme and formation of a heterogeneous
chromophore.
In this work, we hypothesized that A1M, due to its heme-
binding and reductive biochemical properties, can protect
bystanding cells and molecules from oxidative damage by MPO.
To approach this question, we have investigated the reactions
occurring between MPO and A1M and the effects of A1M on the
oxidation of LDL by MPO.
MATERIALS AND METHODS
PROTEINS AND REAGENTS
Recombinant human A1M with an N-terminal His8-tag was
expressed in E. coli, purified and refolded as described by
Kwasek et al. (2007), with the addition of ion-exchange chro-
matography performed as follows. The protein solution was
applied to a column of DEAE-Sephadex A-50 (GE Healthcare,
Uppsala, Sweden) equilibrated with the starting buffer (20mM
Tris-HCl, pH 8.0). A1M was eluted at a flow rate of 1ml/min
using a linear pH gradient consisting of 250ml starting buffer
and 250ml elution buffer (20mM Tris-HCl, 0.15M NaCl,
pH 8.0). Polyclonal rabbit antibodies against A1M were pre-
pared by immunization with human urinary A1M as described
by Berggård and Bearn (1968). Rabbit anti-LIPR antiserum
was prepared by Agrisera AB (Vännäs, Sweden) by immu-
nization with the synthetic peptide CKKLIPR conjugated to
keyhole limpet hemocyanin (KLH). Goat anti-rabbit IgG was
prepared, purified (Björck et al., 1977) and labeled with 125I
using chloramin T as described (Greenwood et al., 1963).
Bovine catalase was from Roche Diagnostics (catalog no. 106810;
Mannheim, Germany). Purified neutrophil MPO was a kind
gift from professor Inge Olsson, Department of Haematology,
Lund University. Purity was assessed by SDS-PAGE as described
below, and activity was estimated by EnzChek Myeloperoxidase
(MPO) Activity Assay Kit (catalog no. E33856; Invitrogen,
Eugene, OR, USA). Heme (ferriprotoporphyrin IX chloride)
was purchased from Porphyrin Products, Inc. (Logan, UT,
USA).
ANALYSIS OF A1M REACTION WITH HEME AND MPO
A1M, 1.2mg/ml, was mixed with MPO, 1.2mg/ml, or heme,
0.4mM, in incubation buffer (25mM sodium phosphate, pH 8)
and incubated at room temperature for 1 or 24 h. The sam-
ples were analyzed by 12% SDS-PAGE with mercaptoethanol and
4–20% non-denaturing PAGE as described below.
To study cleavage efficiency, A1M (0.195mg/ml) was mixed
with different concentrations of MPO (0, 0.3, and 1mg/ml) in
incubation buffer. The samples were incubated at 37◦C for 1, 4,
and 24 h. After incubation, each sample was run on a 10% SDS-
PAGE under reducing conditions. The same procedure was per-
formed with another heme-containing control protein, catalase,
instead of MPO. Samples with 0.195mg/ml A1M and 0.1mg/ml
MPO were also mixed in buffers of different pH (0.3M NaAc, pH
4; 0.3M NaAc, pH 5; 0.3M NaPi, pH 6; 0.3M NaPi, pH 7; 0.3M
NaPi, pH 8; 0.3M glycine-OH, pH 9), incubated at 37◦C for 1 h
and then run on a 12% SDS-PAGE under reducing conditions.
The amounts of non-cleaved and cleaved A1M were estimated by
densitometry of the bands using ImageJ 1.47v software (National
Institutes of Health, USA).
ELECTROPHORESIS ANDWESTERN BLOTTING
SDS-PAGE was performed using the protocol of Laemmli
(1970). Samples were mixed with sample buffer containing
2% (v/v) mercaptoethanol, boiled for approximately 1min
and applied to 12% linear, or 4–20% gradient polyacrylamide
Criterion™ TGX™ Precast Gels (BioRad). Gels were stained
with Coomassie Brilliant Blue R-250 (BDH Chemicals, Ltd.
Poole, UK). High-molecular-mass standards (Rainbow mark-
ers, Amersham Pharmacia Biotech, Uppsala, Sweden) were used.
Native PAGE was performed with no addition of SDS or mer-
captoethanol in buffers and no boiling of samples. Following
electrophoresis, the proteins were electrophoretically transferred
to a PVDF membrane (Immobilon-P, Millipore, Bedford, MA,
USA) as originally described by Matsudaira (1987), using Trans-
Blot Turbo system from Bio-Rad. The membranes were blocked,
incubated with specific rabbit antisera, followed by washing
and incubation with Alexa Fluor 647 goat anti-rabbit IgG (dil
5000x; Molecular Probes). The membranes were developed in a
ChemiDoc MP Imaging system (BioRad).
PROTEIN IDENTIFICATION BY MASS SPECTROMETRY PEPTIDE
MAPPING AND SEQUENCING ANALYSIS
The protein analysis was performed by Alphalyse A/S (Odense,
Denmark). Briefly, the protein samples were reduced and car-
bamidomethylated, and subsequently digested with trypsin. The
resulting peptides were concentrated on a ZipTip micropurifica-
tion column and eluted onto an anchorchip target for analysis on
a Bruker Autoflex Speed MALDI TOF/TOF instrument. MALDI
MS/MS was performed on 15 peptides for partial sequenc-
ing. The MS and MS/MS spectra were combined and used for
database searching. The data were searched against in-house
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protein databases downloaded from NBCI, including the NRDB
database.
ION EXCHANGE CHROMATOGRAPHY OF A1M/MPO SAMPLES
A 100μl sample with A1M and MPO, both 1.2mg/ml in incu-
bation buffer, was incubated for 48 h at room temperature, and
then analyzed by ion exchange chromatography, using an FPLC
system (ÄKTAprime plus, GE Healthcare, UK) with a Mono-Q
column washed with 20mM Tris-HCl, pH 8. The proteins were
eluted with 20mM Tris-HCl, pH 8 by a 0–100% 0.5M NaCl-
gradient and absorbance was measured at wavelengths of 280
and 405 nm. The same procedure was performed with pure A1M
and MPO separately in the same amounts. Fractions correspond-
ing to the observed absorbance peaks were separated by 12%
SDS-PAGEwithmercaptoethanol. Fractions containing A1M that
had reacted with MPO were analyzed by absorbance scanning
between 250 and 750 nm on a Beckman (Beckman Instruments,
Fullerton, CA) DU 800 spectrophotometer using a scan rate of
1200 nm/min. Absorbance scanning was also performed on pure
A1M and MPO for comparison.
PROTON-INDUCED X-RAY EMISSION (PIXE) ANALYSIS
Samples for proton-induced X-ray emission analysis were pre-
pared as follows. Chromatography fractions in 20mM Tris-HCl,
pH 8.0 + 0.1–0.2M NaCl, containing A1M in concentrations
determined by UV-absorbance, were added to a Kimfoil mem-
brane (Kimberley Clark) mounted on a plastic frame and allowed
to dry. At the Lund Nuclear Microprobe facility (Malmqvist et al.,
1993), the samples were placed in a vacuum irradiation cham-
ber and bombarded with a 1 nA proton beam, with an energy of
2.55MeV and accumulating a beam charge of 0.6μC. The char-
acteristic X-rays emitted (Johansson and Campbell, 1988) were
detected using a KETEK AXAS-M H50 SDD Silicon Drift X-
ray detector, while data were collected using KMAX (Sparrow)
software (Elfman et al., 1997). Elemental standards (Fe) were
analyzed in the same way to verify quantification.
NEUTROPHIL GRANULOCYTE ISOLATION AND CULTIVATION
Buffy coat from a healthy donor was mixed with an equal volume
of 2% Dextran in 0.9% NaCl and erythrocytes were allowed to
sediment. The supernatant was aspirated and centrifuged at 200 g
for 10min at 4◦C and the resulting pellet resuspended in 0.9%
NaCl. The resuspension was layered on top of half the volume
of Lymphoprep, centrifuged at 400 g for 25min and the super-
natant removed. Erythrocytes were lysed by addition of ice-cold
H2O and the neutrophils were washed once with 1.8% NaCl cen-
trifuged at 200 g for 6min and washed twice with 0.9% NaCl.
The cells were resuspended in Krebs Ringer glucose-buffer (106
cells/ml) and cultured for 20 h at 37◦C with or without addi-
tion of 1μM ionomycin and 0.1mg/ml A1M. The cells were spun
down and the supernatants analyzed by 12% SDS-PAGE with
mercaptoethanol and Western blotting with anti-A1M antibod-
ies as described above. Supernatants from overnight cultures were
also mixed with A1M (0.1mg/ml) and/or PMSF (1mM), after
centrifugation and separation of the cells, followed by SDS-PAGE
and Western blotting.
LOW DENSITY LIPOPROTEIN OXIDATION INHIBITION AND REDUCTION
Oxidation inhibition and reduction of oxidized LDL was mea-
sured by the thiobarbituric acid (TBA) method described by
Gutteridge (1977). (1) Oxidation: 0.2mg/ml LDL were incubated
with 8mM H2O2 and a dilution series of MPO (25–100μg/ml)
in a total volume of 200μl PBS at 24◦C for 2 h. (2) Inhibition:
0.2mg/ml LDL were incubated with 8mM H2O2, 100μg/ml
MPO or albumin and A1M (8, 20μM) in a total volume of 200μl
PBS at 24◦C for 2 h. 3) Reduction: 0.2mg/ml LDL were incubated
with 8mM H2O2, 100μg/ml MPO in PBS at 24◦C for 2 h, then
different dilutions of A1M (1–10μM) were added in a total vol-
ume of 200μl PBS and the samples were incubated at 24◦C for
1 h. All samples (200μl/sample) were mixed with TBA-reagent
(0.5% 2-thiobarbituric acid and 0.5% SDS in H2O), 0.25ml, and
FIGURE 1 | MPO-induced proteolytic cleavage of A1M. Lane 1 contains
3μg A1M and lane 2 and 3 both contain 3μg A1M mixed with 3μg MPO in
incubation buffer, incubated for 1 and 24 h respectively. (A) SDS-PAGE with
mercaptoethanol. (B) Non-denaturing PAGE without mercaptoethanol.
FIGURE 2 | Western blotting of A1M before and after MPO-induced
cleavage. The samples, 0.1μg of full-length A1M, MPO and a mixture of
A1M/MPO, 0.1μg of each, incubated for 4 h, were separated on a 12%
SDS-PAGE prior to transfer to a PVDF-membrane and blotting. (A) Staining
with Coomassie. (B) Immunoblot with anti-LIPR antibodies.
www.frontiersin.org February 2015 | Volume 6 | Article 11 | 3
Cederlund et al. Activation of A1M by myeloperoxidase
0.2M glycine-HCl, pH 3.6, 0.29ml (Girotti and Thomas, 1984),
was then added and the mixture heated to 95◦C for 15min. The
absorbance at 550 nm was read after cooling to room temper-
ature and centrifugation 3000 rpm/15min. Origin 9.0 software
(OriginLab Corporation, Northampton, MA, USA) was used to
analyze the data.
RESULTS
FORMATION OF T-A1M BY REACTION WITH MPO
A1M and MPO were mixed at the molar ratio 6:1, incubated for
1 and 24 h and analyzed by SDS-PAGE under reducing condi-
tions. As can be seen in Figure 1A, a faster-migrating, truncated
form of A1M was seen after interaction with MPO, indicating
a proteolytic cleavage. The truncated form was similar in size
to t-A1M previously shown to be formed by interaction with
hemoglobin (Allhorn et al., 2002). The MPO-molecule was seen
as two bands corresponding to the two subunit chains of the pro-
tein (Nauseef and Malech, 1986). A larger proportion of A1M
was cleaved in the long-duration reaction (24 h), compared to
the short-duration reaction (1 h), suggesting a time dependent
activity. This difference in cleavage was confirmed by the pres-
ence of two bands in the lane with A1M from the 1 h-reaction,
where all A1M still had not reacted with MPO. SDS-PAGE under
non-reducing conditions of the samples yielded similar results
(not shown). Non-denaturing PAGE was run on the same sam-
ples (Figure 1B) and shows separation based on both size and the
FIGURE 3 | Time- and concentration dependence of MPO-induced
cleavage of A1M. (A) A1M (0.195mg/ml) was incubated with MPO at
concentrations of 0, 0.3, or 1mg/ml for 1, 4, or 24 h at room-temperature.
Ten microliters of the samples were separated on a 12% SDS-PAGE gel in
the presence of mercaptoethanol, and then stained with Coomassie. One
representative experiment is shown. (B) A similar experiment with bovine
catalase under the same conditions was performed.
net-charges of MPO and A1M. Two A1M-bands were seen, prob-
ably representing monomer and dimer. A clear increase of the
net negative charge and/or decrease in size of A1M was seen after
incubation with MPO as compared to A1M alone. Incubation of
A1M with heme also yielded a third band with slower migration
and thus decreased net negative charge (not shown), probably as
a result of attachment of porphyrin and its iron to A1M.
To determine if the cleavage product is t-A1M, defined as
A1M without its C-terminal tetrapeptide LIPR (Allhorn et al.,
2002), a mixture of the two proteins with the molar ratio 1:6
(MPO:A1M) was incubated for 4 h. The cleavage products and
non-cleaved A1M were analyzed by SDS-PAGE and analyzed for
total protein (Figure 2A) and by immunoblotting using anti-
LIPR (Figure 2B) antibodies. As expected, both forms of A1M
were detected after Coomassie staining, while the anti-LIPR anti-
body only bound to full-length A1M. Finally, the two bands, i.e.,
cleaved and non-cleaved A1M-bands were analyzed by trypsin
cleavage and mass-spectrometry after excision from the gel, con-
firming that LIPR was missing in the smaller band. These results
demonstrated that A1Mwas cleaved byMPO in a similar reaction
as with hemoglobin (Allhorn et al., 2002).
A1M CLEAVAGE IS DEPENDENT ON CONCENTRATION, TIME AND pH
Cleavage efficiency was measured in a mix of A1M at 0.195mg/ml
with different concentrations of MPO (0mg/ml, 0.3mg/ml, and
1mg/ml), and different incubation times (1, 4, and 24 h). The
results after SDS-PAGE (Figure 3A) showed increasing cleavage of
A1M with higher concentrations of MPO and longer incubation
times. When comparing the lanes containing MPO at 1mg/ml,
bands for both truncated and full-length A1M was clearly seen in
the gel with samples incubated for 1 h (Figure 3A). The cleavage
was also time-dependent, i.e., more A1Mwas cleaved with time (4
and 24 h; Figure 3A) and after 24 h only the t-A1Mbandwas seen,
suggesting that all A1M had reacted with MPO. A faint t-A1M
FIGURE 4 | pH-dependence of MPO-induced cleavage of A1M. A1M
was mixed with MPO at a concentration of 0.195mg/ml and 0.1mg/ml
respectively, in buffers with different pH. The samples were incubated for
1 h at 37◦C. Ten microliters of the samples were then separated by
SDS-PAGE on 12% gels in the presence of mercaptoethanol. The gels were
stained with Coomassie and quantified by densitometry as described in
Materials and Methods. One representative experiment is shown.
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band was seen with no MPO present. This could be explained by
some cleavage of A1M in the E. coli where A1M was expressed. As
a control, another heme-containing protein, catalase, was incu-
bated with A1M under similar conditions (Figure 3B). This did
not yield any cleavage of A1M as seen by SDS-PAGE. The effi-
ciency of cleavage was also tested at different pH-values (Figure 4)
using 1 h incubation time and a molar ratio of A1M and MPO of
1:3. The mixtures were separated by SDS-PAGE and the relative
amounts of the two bands were estimated by densitometry after
Coomassie staining. As can be seen from Figure 4, most A1M
cleavage occurred in the pH range 6–8 indicating that A1M activ-
ity is most efficient at physiological pH. A lower degree of cleavage
was observed at pH 4, 5, and 9.
HEME GROUP OF MPO IS TRANSFERRED TO A1M
To analyze the reaction products in more detail, A1M and
MPO were incubated at pH 8 for 48 h at the molar ratio 6:1
and then separated by ion exchange chromatography, eluting
FIGURE 5 | Ion exchange chromatography of an A1M/MPO mixture.
(A) A1M and MPO (mol:mol, 6:1) were incubated at room temperature
for 48 h and applied to a Mono-Q column. The column was eluted with
a 0–0.5M sodium chloride gradient in 20mM Tris-HCl, pH 8. Fractions
of 0.5ml were collected and absorbance at 280 and 405 nm measured.
(B) As a comparison, the same procedure was done on a sample with
pure A1M. (C) SDS-PAGE analysis of the peak-fractions, marked 1–4 in
(A,B), obtained after ion exchange chromatography of the A1M/MPO
mix and the pure A1M sample. (D) Absorbance scanning between 250
and 750 nm of fractions obtained after ion exchange chromatography of
the A1M/MPO mix shown to contain t-A1M by SDS-PAGE in (C) (lane
3). As a comparison, the same procedure was done on a sample with
pure A1M and MPO. (E) Size-exclusion chromatography on Superose 12
of a mixture of A1M and MPO (molar ratio 6:1), incubated at
room-temperature for 48 h, followed by analysis of A1M (absorbance
and SDS-PAGE) and iron content measured by PIXE in selected
fractions. The A1M-concentrations are given after dilution three times,
for optimal illustration.
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FIGURE 6 | Cleavage of A1M in neutrophil culture medium. SDS-PAGE
on 12% gels in the presence of mercaptoethanol followed by Western
blotting with anti-A1M antibodies. The left lanes show A1M (0.1mg/ml)
incubated in fresh medium, the middle lanes show A1M incubated with
neutrophil culture medium (0.1mg/ml), and the right lanes show A1M
(0.1mg/ml) incubated with culture medium together with neutrophils
activated by ionomycin. Culture conditions are described in Materials and
Methods. Left panel, incubation for 3 h, and right panel shows the same
procedure but with 24 h incubation.
the proteins by a salt concentration gradient. As a control,
A1M and MPO alone were subjected to the same procedure
(not shown). The eluates were analyzed by absorbance at 280
and 405 nm (Figures 5A,B) and by SDS-PAGE (Figure 5C).
The A1M/MPO mix was eluted as three peaks and, as shown
by SDS-PAGE, the first two peaks contained MPO and the
third peak contained t-A1M. Pure A1M is eluted at a slightly
lower salt concentration than A1M that had reacted with
MPO, which again indicated an increase in net negative
charge. Absorbance scanning showed a maximum at 280 nm
in all samples (Figure 5D), and another absorbance maxi-
mum, at 410–420 nm, was observed in samples with pure MPO
and A1M that had reacted with MPO, but not with pure
A1M. This maximum, a Soret band, is characteristic for the
heme group (Allhorn et al., 2002), and indicates the pres-
ence of heme/porphyrins in MPO as well as in A1M derived
from the mixture. The absorbance spectra suggested that the
heme/porphyrin group was transferred from MPO to A1M when
A1M reacts with MPO.
Iron analysis of the fractions from the ion-exchange chro-
matography showed the presence of iron in the peak A1M-
fraction at a molar ratio of 1:4 (Fe:A1M; not shown). The
A1M+MPO mixture was also separated by gel chromatogra-
phy on Superose 12 followed by iron analysis of the fractions
(Figure 5E). Also in this case, the A1M-containing fractions
showed correlated iron and A1M concentrations, and the A1M-
peak fractions show a molar ratio of 1:10 (Fe:A1M). These results
suggest that the heme-group bound by A1M partially contains the
iron-atom.
FIGURE 7 | A1M inhibits MPO-induced oxidation of LDL. (A) LDL,
0.2mg/ml, was incubated with 8mM H2O2 and a dilution series of MPO
(25–100μg/ml) in a total volume of 200μl PBS at 24◦C for 2 h followed by
(Continued)
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FIGURE 7 | Continued
TBARS analysis. (B) LDL, 0.2mg/ml, was incubated with 8mM H2O2,
100μg/ml MPO and albumin or A1M (8, 20μM) in a total volume of 200μl
PBS at 24◦C for 2 h followed by TBARS analysis. (C) LDL, 0.2mg/ml, was
incubated with 8mM H2O2, 100μg/ml MPO in PBS at 24◦C. After 2 h, a
dilution series of A1M (1–10μM) was added in a total volume of 200μl
PBS, and the samples were incubated at 24◦C for 1 h followed by TBARS
analysis. Results are from triplicate experiments and presented as
mean ± SD.
A1M IS CLEAVED AFTER INCUBATION IN NEUTROPHIL MEDIUM
Neutrophils extracted from buffy coat of a healthy donor were
mixed with 0.1mg/ml A1M in PBS in order to determine whether
A1M would be cleaved by cellular MPO released into the cul-
ture medium. Ionomycin, 1μM, was also added to some samples
to induce degranulation. SDS-PAGE of the medium after 3 and
24 h (Figure 6) shows that t-A1M is formed in the medium, and
the cleavage was complete after 3 h, even without ionomycin-
induced degranulation. After degranulation, the presence ofMPO
in the medium can be seen as two bands, and was confirmed by
immunoblot analysis using anti-MPO antibodies (not shown). T-
A1M is also seen after ionomycin-induced degranulation, but at
lower concentrations, suggesting that proteolytic degradation of
the protein occurs. After 24 h, smaller amounts of t-A1M is seen
with or without ionomycin-addition, again indicating proteolytic
degradation. Addition of A1M to the cell supernatants alone, i.e.,
after centrifugation and removal of the cells, also resulted in the
formation of t-A1M (not shown). Addition of the serine protease
inhibitor PMSF, 1mM, in order to reduce possible interactions
between A1M and the potent neutrophil serine proteases did not
prevent the cleavage of A1M.
A1M INHIBITS LDL OXIDATION BY MPO
LDL, in the presence of H2O2, was oxidized in a dose dependent
fashion by MPO after 2 h incubation (Figure 7A), as measured
by the TBA assay. The oxidation was inhibited by A1M added to
the reaction mixture (Figure 7B). The TBA-signal was reduced to
below the values of non-oxidized LDL by the addition of A1M,
and A1M alone also had some reducing effects on non-oxidized
LDL. To analyze whether A1M also had any effect on LDL after
the oxidation-reaction had occurred, the protein was added only
after 2 h preincubation of MPOwith LDL. As seen in Figure 7C, a
dose-dependent reduction of the TBA-signal was seen, suggesting
that A1M was able to reduce the pre-oxidized LDL.
DISCUSSION
The results of this study show that A1M undergoes a similar reac-
tion with MPO as previously shown with hemoglobin (Allhorn
et al., 2002). The reaction resulted in proteolytic cleavage of
A1M, loss of the C-terminal tetrapeptide, LIPR, and formation
of a truncated form of A1M, called t-A1M. Catalase, another
heme-containing protein, did not induce formation of t-A1M,
suggesting that the cleavage reaction is specific for hemoglobin
and MPO.
The absorbance spectrum of t-A1M after the reaction with
MPO suggests that the heme group is transferred from MPO to
A1M. Also in this respect, the reaction is similar to the reaction
between A1M and hemoglobin (Allhorn et al., 2002). Analysis of
the cleaved A1M after purification from MPO suggests that iron
is still bound to the porphyrin, but at a lower than 1:1 molar
ratio. This is supported by the presence of a Soret band in t-A1M,
which is an indicator of chelated iron. In spite of this, the net neg-
ative charge of t-A1M was increased, as shown by native PAGE
as well as ion exchange chromatography. Part of this increase
could be explained by a loss of the positively charged C-terminal
tetrapeptide LIPR, but it is also possible that other modifications
of A1M are induced by the reaction with MPO. A1M has pre-
viously been shown to bind heme-groups in the molar ratio 1:2
(A1M:heme) (Siebel et al., 2012), and analysis by native PAGE
showed that the A1M:heme complex had an increased net neg-
ative charge (Karnaukhova et al., 2014). In vivo, the lysyl side
groups in positions 92, 118, and 130 are covalently modified
on A1M from plasma and urine, and the modified protein is
brown-colored and has increased negative charge and charge-
heterogeneity (Calero et al., 1996; Berggård et al., 1999; Sala et al.,
2004). Thus, heterogeneous modifications of these lysine residues
as a result of the reaction with the heme-group could possi-
bly explain the increased net negative charge after binding the
heme-group.
In contrast to hemoglobin, the heme-group in MPO is cova-
lently bound to the protein by two ester linkages as well as a
sulfonium ion linkage (Fiedler et al., 2000), suggesting that a
different mechanism is involved when heme is transferred from
MPO to A1M compared to the heme-transfer from hemoglobin.
It can be speculated, however, that similar heme degrading mech-
anisms are involved once the heme-group has been incorporated
to the A1M protein.
Cleavage of A1M was also observed after incubation with
cultured neutrophil granulocytes (Figure 6). The formation of t-
A1M in the culture medium could be verified using anti-LIPR
antibodies (not shown). Addition of ionomycin to the neutrophils
to induce azurophil degranulation and release of MPO as well
as proteolytic enzymes resulted in large amounts of MPO in
the culture medium. However, the concentration of t-A1M was
lower after degranulation, indicating that non-specific prote-
olytic degradation of A1M was taking place after degranulation.
Likewise, longer incubation times, 24 h, also resulted in prote-
olytic loss of the A1M protein. Taken together, the results suggest
that A1M can be proteolytically activated by non-degranulated
neutrophils. In vivo, t-A1M has been detected in several different
physiological tissue fluids, including blood, urine and extravas-
cular fluids (Lopez et al., 1982; Allhorn et al., 2002, 2003). It has
been speculated that t-A1M results from proteolytic cleavage of
full-length A1M induced by free hemoglobin in the tissues, orig-
inating from hemolysis. The results in this paper indicate that
neutrophil-derived MPO also may participate in the formation
of t-A1M in vivo.
For example, t-A1M is known to be present in inflamed tissue
in chronic ulcers (Allhorn et al., 2003). Its role in this context is
unknown but the inhibition of MPO-induced oxidation of LDL,
as shown in Figure 7, suggests that it may be involved in down-
regulating the oxidative stress of hypochlorite and free radicals,
synthesized by MPO during the respiratory burst (Klebanoff,
2005). Therefore, A1M may be part of a defense mechanism
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FIGURE 8 | Tentative function of A1M in protection against bystander
oxidative damage caused by neutrophils. The figure summarizes the
findings of this paper in a physiological context. Recruitment and
activation of neutrophils during inflammation involves MPO-mediated
bacterial killing but may also yield LDL-oxidation as a side-effect. (1)
Neutrophil culture medium or purified MPO induces heme-binding of
A1M, and proteolytic cleavage of the protein which was previously
shown to activate a heme-degradation activity of A1M (Allhorn et al.,
2002). (2) The induced heme-degradation mechanism of A1M is
tentatively “disarming” the peroxidase, preventing oxidative burst. (3)
LDL-oxidation by MPO is inhibited by A1M, and pre-formed oxidation
products on LDL are reduced.
protecting bystander tissues from oxidative damage by the oxida-
tive burst of neutrophils. Such a novel down-regulatory mech-
anism of inflammation may play a role in a wide range of
diseases, such as atherosclerosis, multiple sclerosis, rheumatoid
arthritis, etc.
Figure 8 summarizes a tentative physiological A1M-
dependent mechanism for protection of LDL and bystander
tissues against oxidation from neutrophil oxidative burst. Several
potential mechanisms may explain how A1M achieves the
protection of the LDL-particles. The cleavage of A1M and the
binding and degradation of the heme-group indicates that A1M
can disarm the MPO-enzyme by “stealing” its heme-group.
Previous publications on A1M have shown that it also is a
radical scavenger (Åkerström et al., 2007) and it reasonable to
hypothesize that the protein also may operate by “scavenging,” or
binding, the free radicals and hypochlorite generated by MPO.
It was also shown in this work that oxidized or non-oxidized
LDL-particles could be reduced by A1M even after the formation
of oxidized modifications (Figure 7C). This is analogous to a
similar effect of A1M on collagen fibrils: incubation of heme-
or hydrogen peroxide-oxidized collagen with A1M resulted in
a reduced amount of the oxidation product carbonyl groups
(Olsson et al., 2011; Rutardottir et al., 2013). Mechanistically,
this “cleaning” effect could be explained by the previously
reported reductase activity of A1M (Allhorn et al., 2005), i.e.,
that A1M could chemically reduce the oxidation products in the
macromolecules.
CONCLUSION
MPO induces cleavage of LIPR from A1M in a time-,
concentration- and pH-dependent manner which suggests that
heme is transferred from MPO to A1M. A1M can also protect
LDL against oxidative damage caused by MPO and may thus have
an important role in preventing the formation of atherosclerosis.
Further investigations are needed to clarify detailed mechanisms
involved in the reactions between MPO and A1M, and may
also reveal a correlation between A1M, MPO and patients with
cardiovascular diseases.
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